Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron.
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron.
复制标题
DOI:
10.1016/j.isci.2022.105316
复制
发表时间:
2022-11-18
期刊:
影响因子:
5.8
通讯作者:
Cote, Marceline
中科院分区:
文献类型:
--
作者:
Benlarbi, Mehdi;Laroche, Genevieve;Fink, Corby;Fu, Kathy;Mulloy, Rory P.;Phan, Alexandra;Ariana, Ardeshir;Stewart, Corina M.;Prevost, Jeremie;Beaudoin-Bussieres, Guillaume;Daniel, Redaet;Bo, Yuxia;El Ferri, Omar;Yockell-Lelievre, Julien;Stanford, William L.;Giguere, Patrick M.;Mubareka, Samira;Finzi, Andres;Dekaban, Gregory A.;Dikeakos, Jimmy D.;Cote, Marceline
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike glycoprotein (S) binds to angiotensin-converting enzyme 2 (ACE2) to mediate membrane fusion via two distinct pathways: 1) a surface, serine protease-dependent or 2) an endosomal, cysteine protease-dependent pathway. In this study, we found that SARS-CoV-2 S has a wider protease usage and can also be activated by TMPRSS13 and matrix metalloproteinases (MMPs). We found that MMP-2 and MMP-9 played roles in SARS-CoV-2 S cell-cell fusion and TMPRSS2- and cathepsin-independent viral entry in cells expressing high MMP levels. MMP-dependent viral entry required cleavage at the S1/S2 junction in viral producer cells, and differential processing of variants of concern S dictated its usage; the efficiently processed Delta S preferred metalloproteinase-dependent entry when available, and less processed Omicron S was unable to us metalloproteinases for entry. As MMP-2/9 are released during inflammation, they may play roles in S-mediated cytopathic effects, tropism, and disease outcome. MMP-2 and MMP-9 enable SARS-CoV-2 S-mediated syncytia in the absence of TMPRSS2 SARS-CoV-2 can enter cells via MMPs in a TMPRSS2- and cathepsin-independent manner MMP-dependent S activation requires prior S1/S2 processing Delta S can readily use MMPs for entry while Omicron S cannot Biological sciences; Molecular biology; Microbiology; Virology
登录
查看更多内容
影响因子:
5.4
作者:
Heurich, Adeline;Hofmann-Winkler, Heike;Poehlmann, Stefan
通讯作者:
Poehlmann, Stefan
影响因子:
5.4
作者:
Glowacka, Ilona;Bertram, Stephanie;Poehlmann, Stefan
通讯作者:
Poehlmann, Stefan
DOI:
10.1016/j.biopha.2021.112067
发表时间:
2021-10
期刊:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
影响因子:
--
作者:
D Avila-Mesquita C;Couto AES;Campos LCB;Vasconcelos TF;Michelon-Barbosa J;Corsi CAC;Mestriner F;Petroski-Moraes BC;Garbellini-Diab MJ;Couto DMS;Jordani MC;Ferro D;Sbragia L;Joviliano EE;Evora PR;Carvalho Santana R;Martins-Filho OA;Polonis K;Menegueti MG;Ribeiro MS;Auxiliadora-Martins M;Becari C
通讯作者:
Becari C
影响因子:
5.3
作者:
Carter-Timofte, Madalina Elena;Arulanandam, Rozanne;Olagnier, David
通讯作者:
Olagnier, David
影响因子:
9.9
作者:
Hikmet, Feria;Mear, Loren;Lindskog, Cecilia
通讯作者:
Lindskog, Cecilia